Previous PostAbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
Next PostPalvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support Commercialization of Novel Therapies for Serious, Rare Genetic Skin Diseases